Dermata Therapeutics, Inc. (DRMA)
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.
Address
3525 DEL MAR HEIGHTS RD., #322
SAN DIEGO, CA 92130
Founded
2014
Number of Employees
8
Website
http://www.dermatarx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)